Showing results (201-210 of 298) with videos related to
Sort By:
Pageof 30
Transplant International : Official Journal of the European Society for Organ Transplantation|December 25, 2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseKerstin Herzer, Tania M Welzel, Ulrich Spengler, et al.Hepatology (Baltimore, Md.)|October 11, 2008
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, et al.Radiology|August 10, 2021
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19Dmitrij Kravchenko, Alexander Isaak, Sebastian Zimmer, et al.International Journal of Molecular Sciences|December 11, 2022
Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian PatientsHans Dieter Nischalke, Franziska Schmalz, Stephan Buch, et al.Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 7, 2019
The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical InterventionsLeah Maria Klein, Johannes Chang, Wenyi Gu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2005
Budesonide in previously untreated autoimmune hepatitisJohannes Wiegand, Andreas Schüler, Stephan Kanzler, et al.Journal of Hepatology|April 30, 2013
Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis CBettina Langhans, Benjamin Krämer, Marcell Louis, et al.Hepatology (Baltimore, Md.)|July 4, 2009
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patientsThomas Berg, Viola Weich, Gerlinde Teuber, et al.Journal of Hepatology|December 17, 2011
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadKarin Neukam, Angela Camacho, Antonio Caruz, et al.Pageof 30